Skip to Main Content

Paper Details

Longitudinal utilization of systemic immunomodulators before and after dupilumab approval in children with atopic dermatitis.
Pediatr Dermatol
1
2023
Author NameAffiliation
Sebastian SchneeweissDivision of Pharmacoepidemiology, Brigham and Women's Hospital
Sebastian SchneeweissHarvard Medical School
  • 1 - 2

Datasets

Release 1.2